SCHEMBL347178

SCHEMBL347178

[CH2]C(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23451596 0.95
Hydrochloric Acid SCHEMBL15573904 0.95
SCHEMBL16965289 0.89 ALDH1A1 (0.40)
SCHEMBL7441151 0.74
SCHEMBL19971146 0.71 ALDH1A1 (0.33)
SCHEMBL10876137 0.71 ALDH1A1 (0.62)
SCHEMBL7618 0.71
SCHEMBL1193514 0.71
SCHEMBL10474909 0.71
SCHEMBL2814 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108727459-B Tripterine aptamer conjugate and preparation method and application thereof 北京和理咨询有限公司 2021-05-04 CN claimed
CN-112480013-A 3, 4-dihydropyrimidine benzonitrile derivative, and preparation method and application thereof 湖南千金湘江药业股份有限公司 2021-03-12 CN claimed
CN-108409740-B Preparation method of Aidallas 盐城师范学院 2020-05-08 CN claimed
CN-111066779-A Pesticide synergistic additive and method for reducing pesticide dosage 江西中迅农化有限公司 2020-04-28 CN claimed
US-20130072687-A1 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-03-21 US claimed
EP-2491018-A1 PROCESS FOR PREPARING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2012-08-29 EP claimed
US-20110124869-A1 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-05-26 US claimed
WO-2011050215-A1 PROCESS FOR PREPARING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-28 WO claimed
US-20100056808-A1 PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN ALPHORA RESEARCH INC. (CA) 2010-03-04 US claimed
US-20100056807-A1 PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN ALPHORA RESEARCH INC. (CA) 2010-03-04 US claimed
US-7244857-B2 Method of making hydroxyalkyl amide containing reduced level of unreacted alkanolamine CROMPTON CORPORATION (US) 2007-07-17 US claimed
US-20050107623-A1 Method of making hydroxyalkyl amide containing reduced level of unreacted alkanolamine CHEMTURA CORPORATION 2005-05-19 US claimed
WO-2003008432-A1 PROCESS FOR THE PREPARATION OF ALPHA MODIFIED NUCLEOSIDE TRIPHOSPHATES AND COMPOUNDS THEREFROM ISIS PHARMACEUTICALS, INC. (US) 2003-01-30 WO claimed
CN-1242780-A Components and catalysts for the polymerization of olefins MONTELL TECHNOLOGY COMPANY BV (NL) 2000-01-26 CN claimed
EP-0567637-A1 BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1993-11-03 EP claimed
WO-1993009092-A1 BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1993-05-13 WO claimed
CN-113660932-B Phenyl derivatives having pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same 景凯生物科技股份有限公司 2024-07-12 CN disclosed
US-20240190866-A1 POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF ACADEMIA SINICA (TW) 2024-06-13 US disclosed
EP-0076576-A1 Use of a catalyst and process for polymerizing olefins MOBIL OIL CORPORATION (US) 1983-04-13 EP disclosed
US-4376722-A Alkyltitanium and alkylchromium catalysts for olefin polymerization MOBIL OIL CORPORATION (US) 1983-03-15 US disclosed